Siret D, Bretaudeau G, Branger B, Dabadie A, Dagorne M, David V, de Braekeleer M, Moisan-Petit V, Picherot G, Rault G, Storni V, Roussey M
Clinique Médicale Pédiatrique, Hôpital de la Mère et de l'Enfant, CHU Nantes, Nantes, France.
Pediatr Pulmonol. 2003 May;35(5):342-9. doi: 10.1002/ppul.10259.
Until the year 2000, systematic cystic fibrosis (CF) neonatal screening was only performed in a few regions of France. The Brittany region began in 1989, but not the neighboring region of Loire-Atlantique. The present study compares the clinical evolution of both affected populations 10 years after screening was started. Although the 77 screened and 36 nonscreened children were followed in different CF centers, they were included in similar care protocols. The clinical characteristics at diagnosis and their evolution over a 10-year period of all the children affected with CF and born between January 1, 1989 and December 31, 1998, excluding those with meconium ileus, were compared. There were no significant differences in sex ratio, gestational age, anthropometric data at birth, frequency of deltaF508 homozygotes, proportion of pancreatic-insufficient patients, and mean age between the two populations. Age at diagnosis was lower in the screened group (38 days vs. 472 days, P < 10(-7)), as was the delay in supplementation with pancreatic enzymes (1.7 months vs.15.9 months, P < 10(-7)). The proportion of children who were hospitalized at least once was higher among the nonscreened than the screened patients (86% vs. 49%, P < 10(-4)). Z-scores for weight and height were significantly better in the screened population, not only in the first years of life, but also at 5 years old for height and 8 years old for weight. The Shwachman and Brasfield scores were higher among the screened children during the whole period of follow-up. No significant differences in colonization by Pseudomonas aeruginosa nor in lung function were found. Given the homogeneity in the characteristics and the follow-up of both populations, the benefits in terms of nutrition and clinical well-being of neonatal screening appear to be clear, thus confirming the advantages of its general implementation.
直到2000年,系统性囊性纤维化(CF)新生儿筛查仅在法国的少数地区开展。布列塔尼地区于1989年开始筛查,但邻近的大西洋卢瓦尔省却未开展。本研究比较了筛查开始10年后两个受影响人群的临床演变情况。尽管77名接受筛查的儿童和36名未接受筛查的儿童在不同的CF中心接受随访,但他们都被纳入了相似的护理方案。对1989年1月1日至1998年12月31日期间出生且患有CF(不包括胎粪性肠梗阻患儿)的所有儿童在诊断时的临床特征及其10年期间的演变情况进行了比较。两组人群在性别比例、胎龄、出生时人体测量数据、ΔF508纯合子频率、胰腺功能不全患者比例以及平均年龄方面均无显著差异。筛查组的诊断年龄较低(38天对472天,P < 10⁻⁷),补充胰酶的延迟时间也较短(1.7个月对15.9个月,P < 10⁻⁷)。未接受筛查的患者中至少住院一次的儿童比例高于接受筛查的患者(86%对49%,P < 10⁻⁴)。筛查人群的体重和身高Z评分显著更好,不仅在生命的最初几年如此,在5岁时的身高和8岁时的体重方面也是如此。在整个随访期间,接受筛查的儿童的施瓦克曼和布拉斯菲尔德评分更高。在铜绿假单胞菌定植和肺功能方面未发现显著差异。鉴于两组人群在特征和随访方面的同质性,新生儿筛查在营养和临床健康方面的益处似乎很明显,从而证实了全面实施筛查的优势。